Table 1.
OPTIONS-DC Conference (N = 68 patients totaling 73 admissions) | No OPTIONS-DC Conference (N = 85 patients totaling 100 admissions) | |||
---|---|---|---|---|
n | % | n | % | |
Age: median (range) | 38 | 19–65 | 42 | 19–65 |
Male | 42 | 61.8 | 63 | 74.1 |
White | 62 | 91.2 | 80 | 94.1 |
Medicaid insurance | 59 | 86.8 | 67 | 78.8 |
Unstable housing | 36 | 52.9 | 51 | 60.0 |
Reported substance use | ||||
Methamphetamine | 58 | 85.3 | 60 | 70.6 |
Opioid | 56 | 82.4 | 57 | 67.0 |
Alcohol | 7 | 10.3 | 17 | 20.0 |
Cannabis | 21 | 30.9 | 30 | 35.3 |
Benzodiazepine | 7 | 10.3 | 11 | 12.9 |
Tobacco | 57 | 83.8 | 72 | 84.7 |
Number of substances used | ||||
1 | 10 | 14.7 | 24 | 28.2 |
2 | 38 | 55.9 | 35 | 41.2 |
>2 | 17 | 25.0 | 25 | 29.4 |
Injection drug use reported | 63 | 92.6 | 69 | 81.2 |
Any psychiatric disorder | 43 | 63.2 | 55 | 64.7 |
HCV-positive antibody or PCR | 51 | 75.0 | 50 | 58.8 |
Bacteremia | 50 | 73.5 | 46 | 54.1 |
Endocarditis | 27 | 39.7 | 17 | 20.0 |
Vertebral osteomyelitis | 31 | 45.6 | 13 | 15.3 |
Epidural abscess | 24 | 35.3 | 8 | 9.4 |
Septic arthritis | 13 | 19.1 | 8 | 9.4 |
MRSA | 28 | 41.2 | 27 | 31.8 |
MSSA | 25 | 36.8 | 23 | 27.1 |
HCV, hepatitis C virus; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-sensitive Staphylococcus aureus; PCR, polymerase chain reaction.